<?xml version="1.0" encoding="UTF-8"?>
<snippetsTree>
 <snippets file="drug\PMC7242950\results\search\testTrace\results.xml">
  <result pre="doi: 10.1016/j.medcle.2020.04.002 : Article Use of antimalarial drugs in the" exact="treatment" post="of COVID-19: A window of opportunity?â˜†Uso de antipalÃºdicos en"/>
  <result pre="hypothesized the possible usefulness of chloroquine and hydroxychloroquine in the" exact="treatment" post="of SARS-CoV,1 prompting several studies in subsequent years trying"/>
  <result pre="its immunomodulatory effect, which justifies its use in the chronic" exact="treatment" post="of rheumatoid arthritis and systemic lupus erythematosus, may be"/>
  <result pre="should be used with caution because they could prolong the" exact="infection" post="time by depressing the immune system,5, 7 the combined"/>
  <result pre="The first study of the use of chloroquine in coronavirus-19" exact="infection" post="was conducted in China and was published on 4th"/>
  <result pre="by preventing the entry of the virus into cells, 3" exact="treatment" post="regimens were tested that verified the inhibitory potential of"/>
  <result pre="Vero cells infection, while remdesivir was only effective with the" exact="infection" post="already established.8 The fact that the concentration with which"/>
  <result pre="discharge of patients would reduce hospital saturation and optimize the" exact="treatment" post="offered. In addition, the use of hydroxychloroquine has the"/>
  <result pre="significant statistical power.17 The in vivo assessment of the prophylactic" exact="treatment" post="is still pending, as well as the publication of"/>
  <result pre="controversy about the generalized use of antimalarial drugs in the" exact="treatment" post="of COVID-19.18 All drugs need to meet efficacy and"/>
  <result pre="and projection of optimized dosing design of hydroxychloroquine for the" exact="treatment" post="of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)Clin. Infect."/>
  <result pre="vitroCell Res.30202026927110.1038/s41422-020-0282-032020029 9GaoJ.TianZ.YangX.Breakthrough: chloroquine phosphate has shown apparent efficacy in" exact="treatment" post="of COVID-19 associated pneumonia in clinical studiesBiosci Trends142020727310.5582/bst.2020.0104732074550 10General"/>
  <result pre="clinical studiesBiosci Trends142020727310.5582/bst.2020.0104732074550 10General Office of National Health CommissionDiagnostic and" exact="treatment" post="protocol for novel coronavirus pneumonia (trial version 6)2020117Available from:"/>
  <result pre="novel coronavirus pneumonia (trial version 6)2020117Available from: http://www.gov.cn/zhengce/zhengceku/2020-02/19/content_5480948.htm 11MarmorM.F.KellnerU.LaiT.Y.Y.MellesR.B.MielerW.F.LumF.Recommendations on" exact="screening" post="for chloroquine and hydroxychloroquine retinopathy (2016 revision)Ophthalmology12320161386139410.1016/j.ophtha.2016.01.05826992838 12Agencia EspaÃ±ola"/>
  <result pre="Hidroxicloroquina Ratiopharm 200Â mgOctubre 201111110.1017/CBO9781107415324.004 13GautretP.LagierJ.-C.ParolaP.HoangV.T.MeddebL.MailheM.Hydroxychloroquine and azithromycin as a" exact="treatment" post="of COVID-19: results of an open-label non-randomized clinical trialInt."/>
  <result pre="a retrospective cohort studyLancet39520201054106210.1016/s0140-6736(20)30566-332171076 17ChenJ.LiuD.LiuL.A pilot study of hydroxychloroquine in" exact="treatment" post="of patients with common coronavirus disease-19 (COVID-19)J Zhehiang Univ492020Available"/>
  <result pre="Drug Metab Toxicol720111153116710.1517/17425255.2011.59850621736423 21ChorinE.DaiM.ShulmanE.WadhwainL.CohenR.B.BarbhaiyaC.The QT interval in patients with SARS-CoV-2" exact="infection" post="treated with hydroxychloroquine/azithromycinmedRxiv212020202010.1101/2020.04.02.20047050 22Generalitat de CatalunyaNota Informativa Sobre lâ€™"/>
 </snippets>
</snippetsTree>
